Terminated NA INTERVENTIONAL 1-arm NCT00145587

Stem Cell Transplantation for Children Affected With Osteopetrosis

Allogeneic Hematopoietic Stem Cell Transplantation for Children Affected With Malignant Osteopetrosis: A Pilot Study

Sponsor: St. Jude Children's Research Hospital

Interventions Miltenyi Biotec CliniMACS Stem Cell Transplantation Systemic chemotherapy and antibodies

Updated 10 times since 2017 Last updated: Apr 24, 2017 Started: Jul 31, 2004 Primary completion: Feb 28, 2009 Completion: Feb 28, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Due to the principal investigator having left the institution.

This NA trial investigates Osteopetrosis and is currently terminated or withdrawn. St. Jude Children's Research Hospital leads this study, which shows 10 recorded versions since 2004 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Jan 2026 — Present [monthly]

Terminated NA
Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2023 — Jul 2024 [monthly]

Terminated NA
Dec 2022 — Jan 2023 [monthly]

Terminated NA

▶ Show 5 earlier versions

Dec 2021 — Dec 2022 [monthly]

Terminated NA
Jan 2021 — Dec 2021 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Feb 2017 — Jun 2018 [monthly]

Terminated NA
Jan 2017 — Feb 2017 [monthly]

Terminated NA

First recorded

Jul 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

St. Jude Children's Research Hospital

Data source: St. Jude Children's Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Memphis, United States